XML 22 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities    
Net loss $ (31,849) $ (595)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Provision for loan losses 57,708 38,626
Depreciation and amortization 4,435 2,943
Amortization of debt issuance costs 2,969 1,332
Stock-based compensation 7,662 4,358
Amortization of net deferred origination costs 16,008 18,317
Changes in servicing rights, at fair value 3,074 0
Gain on sales of loans (9,924) (18,389)
Unfunded loan commitment reserve (625) 807
Gain on extinguishment of debt (562) (48)
Changes in operating assets and liabilities:    
Other assets 18 (8,823)
Accounts payable 1,175 2,946
Interest payable 372 (156)
Accrued expenses and other liabilities (229) 7,352
Originations of loans held for sale (167,207) (196,119)
Payments of net deferred origination costs of loans held for sale (5,769) (7,954)
Proceeds from sale of loans held for sale 170,043 204,025
Principal repayments of loans held for sale 5,014 1,664
Net cash provided by operating activities 52,313 50,286
Cash flows from investing activities    
Change in restricted cash (1,353) 1,179
Purchases of property, equipment and software (5,494) (3,896)
Capitalized internal-use software (2,610) (2,254)
Originations of term loans and lines of credit, excluding rollovers into new originations (862,454) (511,726)
Proceeds from sale of loans held for investment 41,375 58,901
Payments of net deferred origination costs (21,033) (17,332)
Principal repayments of term loans and lines of credit 547,305 411,628
Purchases of term loans (6,672) 0
Other (201) 0
Net cash used in investing activities (311,137) (63,500)
Cash flows from financing activities    
Proceeds from exercise of stock options and warrants 104 187
Payments of initial public offering costs 0 (1,845)
Purchase of shares for treasury (254) (184)
Investments by noncontrolling interests 0 7,069
Issuance of common stock under employee stock purchase plan 1,487 0
Payments of debt issuance costs (3,740) (1,133)
Net cash provided by (used in) financing activities 176,897 (27,404)
Effect of exchange rate changes on cash and cash equivalents 168 (123)
Net decrease in cash and cash equivalents (81,759) (40,741)
Cash and cash equivalents at beginning of period 159,822 220,433
Cash and cash equivalents at end of period 78,063 179,692
Supplemental disclosure of other cash flow information    
Cash paid for interest 9,447 8,087
Supplemental disclosures of non-cash investing and financing activities    
Stock-based compensation included in capitalized internal-use software 647 360
Unpaid principal balance of term loans rolled into new originations 129,688 127,174
Funding debt    
Cash flows from financing activities    
Proceeds from the issuance of funding debt 491,742 110,728
Repayment of debt (312,442) (130,226)
Corporate debt    
Cash flows from financing activities    
Repayment of debt $ 0 $ (12,000)